Article · 14 min read · Written by Dr. Lisa L. Johnson, M.D.
Percutaneous Tibial Nerve Stimulation for Overactive Bladder
Learn how percutaneous tibial nerve stimulation for overactive bladder works, who may be a candidate, and what PTNS visits involve.
If you plan errands around nearby bathrooms, wake several times a night to urinate, or feel a sudden urge that leaves little time to reach the toilet. You are not dealing with a personal failing. You are also not dealing with something you simply have to accept with age. Overactive bladder symptoms can narrow daily life, but they are treatable and deserve a thoughtful evaluation.
Percutaneous tibial nerve stimulation for overactive bladder, often called PTNS, is a nonsurgical office treatment that uses gentle nerve stimulation to help regulate bladder signaling. It may be considered when urgency, frequency, or urge incontinence continues despite earlier steps, but it is not the right choice for every patient.
At Pelvic Health Institute of Illinois, treatment decisions begin with your symptoms, health history, and goals. PTNS is one option in a broader, conservative-first approach, and understanding how it works can help you have a more informed conversation about your care.
What is percutaneous tibial nerve stimulation for overactive bladder?
Overactive bladder (OAB) is a pattern of bladder symptoms that can make ordinary decisions feel complicated. A sudden urge may interrupt work, travel, sleep, exercise, or time with family. Some people also experience frequent urination or leakage before reaching the bathroom. OAB affects an estimated 10 to 15 percent of women, and the impact can extend beyond the bladder itself, affecting productivity and social and emotional well-being. These symptoms deserve medical attention. They are not something you simply have to accept as part of getting older.
There is no single treatment that is right for everyone. Behavioral changes, such as bladder retraining and avoiding individual bladder irritants, may be an appropriate starting point. However, those steps do not adequately control symptoms for every patient. A clinician may then discuss medication or an office-based treatment, depending on the person's symptoms, health history, and previous care. You can review the broader range of overactive bladder treatment options while keeping the focus of this article on one specific approach.
What PTNS means
Percutaneous tibial nerve stimulation, usually called PTNS, is a focused form of neuromodulation. It uses gentle electrical stimulation near the tibial nerve to influence the nerve signals involved in bladder control. The goal is to help regulate bladder activity and reduce symptoms such as urgency, frequency, and urinary incontinence. PTNS is nonsurgical and does not require a medication to produce its effect.
In other words, PTNS does not treat OAB by asking you to ignore the urge or by simply restricting your daily life. It is an office treatment intended to address the signaling involved in bladder symptoms. Research has reported improved bladder control and reductions in urinary urgency and frequency compared with control groups. Some patients have also reported symptom improvement lasting one to three months after treatment. These findings describe what has been observed in research, not a guaranteed result for an individual patient.
Where PTNS fits in OAB care
PTNS is commonly discussed as one of the treatment options used when symptoms need more support than behavioral changes alone can provide. Clinical literature groups it with other later-line options, including bladder Botox and sacral neuromodulation. That classification does not mean every patient must try the same treatments in the same order. It means there is a broader toolbox when urgency, frequency, or urge leakage continues to interfere with life.
PTNS may be relevant for someone looking for a nonsurgical option, but candidacy requires an individual evaluation. OAB symptoms can have different contributors, and treatment should be selected after a clinician reviews the pattern rather than relying on symptoms alone. If leakage is part of your experience, learn more about urinary incontinence treatment as part of that conversation.
How does PTNS work?
Percutaneous tibial nerve stimulation, usually called PTNS, uses a nerve pathway in the lower leg to influence the signals involved in bladder control. It is an office-based, nonsurgical treatment. Instead of placing a device in the bladder or operating on the pelvic organs, a clinician applies gentle electrical stimulation near the inner ankle.
A small electrode near the inner ankle
During treatment, a very thin needle electrode is placed near the tibial nerve, above and slightly behind the bony prominence on the inside of the ankle. In the protocol described in the medical literature. The needle is positioned approximately 3 centimeters above and 2 centimeters behind the medial malleolus, the clinical term for that ankle bone. This location allows the electrode to reach the tibial nerve pathway without placing the needle near the bladder itself. Medical research describes the needle location and PTNS technique.
How the stimulation reaches bladder-control pathways
The tibial nerve carries signals that connect with nerve pathways in the lower spine and pelvis. PTNS sends mild electrical impulses through this pathway. The goal is to help regulate the nerve signaling that affects bladder activity. During a session, you may notice a light tingling or a small sensation in the foot or ankle as the stimulation is adjusted. The intensity is set by the treating clinician for the session, and it should not be presented as a test of how much discomfort you can tolerate.
By influencing these signals, PTNS may help reduce symptoms such as urinary urgency, frequent urination, and urge-related leakage. It is not a guarantee of improvement, and it is not the right choice for every person. A clinician considers your symptoms, health history, and previous treatments before discussing whether PTNS fits your care plan.
Why treatment is a series of visits
PTNS works as a treatment course rather than a one-time procedure. Pelvic Health Institute of Illinois documents an office pattern of about 30 minutes per visit, with 12 weekly sessions as the initial course. The schedule requires planning, but each appointment is relatively brief. The University of Colorado Anschutz Medical Campus likewise describes 12 weekly visits followed by monthly treatment for patients who need ongoing support. Its patient information also notes that the FDA approved PTNS as an OAB treatment option in 2011. Review the clinical overview of PTNS visits and treatment scheduling.
Your response and next steps should be reviewed with your clinician throughout the course. If urgency, frequency, nighttime urination, or urge leakage is limiting your daily life, an individualized evaluation can help clarify whether PTNS or another treatment option makes sense.
Who may be a candidate for PTNS?
There is no single symptom checklist that determines whether percutaneous tibial nerve stimulation is appropriate. PTNS is considered after a clinician understands how bladder symptoms affect your daily life, what has already been tried, and what matters most to you. The goal is not to match every patient to the same treatment. It is to choose an option that fits your symptoms, health history, and preferences.
Evaluation may include the pattern and severity of urinary urgency, daytime frequency, nighttime urination, and urge leakage. Your clinician may also ask how often you need to plan around a bathroom, whether symptoms interrupt sleep or activities, and whether you have noticed changes over time. These details help distinguish the symptoms that are most important to address and provide a baseline for discussing progress later.
What your health history adds
Overall health and underlying medical conditions are part of the decision. Published clinical guidance notes that providers consider OAB symptom severity, overall health, and other conditions when deciding whether PTNS may be a good treatment option. You can review the research discussion in this peer-reviewed review of PTNS, but it should not be used to diagnose yourself or determine eligibility without a clinical evaluation.
A whole-system pelvic-health perspective matters because urgency, frequency, and leakage can occur alongside other bladder or pelvic conditions. Pelvic organ prolapse, for example, can contribute to OAB symptoms. A clinician may therefore consider the broader picture rather than treating one symptom in isolation. If you are unsure where to begin, an evaluation for pelvic floor disorder care can help clarify which symptoms need attention and which treatment paths may be reasonable.
Previous treatment and personal goals
Your prior experience also matters. Some patients are looking for a non-surgical option after behavioral strategies or medication have not provided enough relief. While others want to understand their choices before moving to a different treatment. Medication side effects, the burden of urgency at work or while traveling, and your willingness to attend a series of office visits may all shape the conversation. PTNS is not a promise to stop medication or avoid every other treatment. It is one option that can be weighed alongside the alternatives.
Dr. Johnson can review your symptoms, health history, prior treatment, and goals in plain language before recommending a next step. Because symptoms can have different causes, speak with a qualified clinician for diagnosis and individualized treatment advice rather than trying to determine candidacy from this article alone.
What should you expect during and after PTNS treatment?
- Prepare for a series, not a one-time visit. At Pelvic Health Institute of Illinois, PTNS is offered as an office treatment for overactive bladder and urge incontinence. The initial course is typically 12 weekly sessions. Each visit is planned for about 30 minutes, and office procedures are available at the Oak Lawn or Orland Park locations. Before treatment begins, your clinician will review your bladder symptoms, health history, and previous treatments so you can decide whether this approach fits your care plan.
- Set aside time for a focused office visit. You can expect the visit to center on the treatment itself and on any questions about your symptoms or progress. The 30-minute visit length is consistent with published descriptions of initial PTNS sessions, which are generally scheduled weekly for 12 visits. This schedule matters because the treatment is designed as a course of care rather than an isolated procedure. The University of Colorado Anschutz Medical Campus describes the initial course as 12 weekly office visits.
- Expect placement near the ankle. PTNS uses a small needle placed near the tibial nerve in the lower leg, above and behind the inner ankle bone. One published protocol describes placement approximately 3 centimeters above and 2 centimeters behind the medial malleolus, the bony prominence on the inside of the ankle. An electrode and stimulation device are then used as part of the treatment. The exact setup and stimulation level are managed by the clinician during the visit, so ask for an explanation if any part of the process is unclear.
- Allow the stimulation session to run its course. During treatment, electrical stimulation is directed along the tibial nerve pathway. The goal is to influence nerve signaling involved in bladder control. Do not assume that a particular sensation or immediate change is required for the treatment to be meaningful. Tell the treating clinician what you notice during the session, and ask what to expect based on your individual setup. Avoid predicting your response from one visit alone.
- Return to your usual plans unless your clinician tells you otherwise. After each appointment, your clinician can answer questions about what you should monitor and when to report a concern. Published patient guidance emphasizes completing the initial 12 treatments before evaluating whether PTNS is helping. Some sources describe changes in bladder control becoming noticeable around five to seven weeks, while other guidance notes that improvement may take up to eight weeks. These timelines are not promises, and your own response should be discussed during follow-up.
- Discuss maintenance after the initial course. If PTNS is helping, ask how improvement will be monitored and whether maintenance visits may be appropriate. Guidance from the University of Colorado describes monthly treatment after the initial 12 weekly visits to help sustain improvement. Other professional guidance describes top-up sessions at variable intervals. Your schedule should be individualized rather than assumed in advance.
- Bring practical questions to each appointment. Consider asking: What changes should I track in urgency, frequency, nighttime urination, or urge leakage? When will we review my progress? What happens if I miss a weekly visit? If symptoms improve, how will we decide whether to continue with maintenance? A bladder diary can help you and your clinician discuss patterns, but ask whether one is useful for you before starting one.
PTNS vs. medication, Botox, and sacral neuromodulation
There is no single treatment that is right for every person with overactive bladder. Bladder retraining and lifestyle changes are often considered first, but they may not adequately control symptoms for everyone. When additional treatment is appropriate, options can include medication, percutaneous tibial nerve stimulation (PTNS), bladder Botox, and sacral neuromodulation. Clinical guidance commonly places PTNS, Botox, and sacral neuromodulation among third-line options. But the order and combination should reflect your symptoms, health history, preferences, and response to earlier care. Urogynecology care for bladder symptoms can help you compare these choices thoughtfully.
| Option | What it is | Treatment pattern | Considerations |
|---|---|---|---|
| Medication | Prescription treatment intended to change bladder activity. Options described in the medical literature include antimuscarinics, beta-3 agonists, and desmopressin. | The medication and dosing schedule depend on the prescription and your clinical situation. | Potential side effects vary by medication. Reported examples include dry mouth, constipation, blurred vision, and headaches. |
| PTNS | A nonsurgical form of neuromodulation that uses stimulation near the ankle to influence nerve signaling involved in bladder control. | A common initial course involves 12 weekly office visits, followed by maintenance treatment when recommended. | It requires a regular visit commitment. Mild, temporary discomfort, tingling, or irritation at the insertion site can occur. |
| Bladder Botox | One of the procedural treatment categories used for overactive bladder, involving botulinum toxin treatment in the bladder. | The timing and need for repeat treatment are determined by the treating clinician. | It is a different procedural approach from PTNS and should be considered in the context of your symptoms and medical history. |
| Sacral neuromodulation | An implanted neuromodulation option included among recognized third-line treatments for overactive bladder. | Because it involves an implant, the treatment pathway differs substantially from recurring office-based PTNS visits. | The decision requires an individualized discussion of the procedure, device-based treatment, and your long-term goals. |
PTNS may appeal to someone looking for a nonsurgical option that does not require taking a daily bladder medication. It still involves commitment: a typical course is 12 weekly treatments, and maintenance may be discussed afterward. Mild irritation, redness, bleeding at the needle site, or temporary ankle aching have been reported. While some patients experience mild tingling or discomfort that resolves soon after a session. These possibilities should be weighed alongside medication effects, the procedural nature of Botox, and the implant-based pathway of sacral neuromodulation.
The goal is not to choose the most advanced-sounding treatment. It is to identify the approach that fits your bladder symptoms, other health conditions, prior treatment experience, and willingness to follow the treatment schedule. A careful evaluation can also clarify whether urgency, frequency, nighttime urination, or urge leakage reflects overactive bladder alone or another pelvic health concern. Dr. Johnson can explain where PTNS fits within a conservative-first plan and what alternatives may make sense for you.
Not sure whether PTNS is right for you? Schedule with Dr. Johnson.
Frequently Asked Questions
Does PTNS work for overactive bladder?
PTNS can improve urgency, frequency, and urge incontinence for some patients, but it does not work the same way for everyone. Research has found improved bladder control compared with control groups, and some patients report symptom improvement lasting one to three months after treatment. Your clinician can help you evaluate whether the response is meaningful for your daily life. Read the research summary.
How much does PTNS cost?
There is no single cost that applies to every patient. Your estimate depends on your insurance plan, benefits, and clinical care. Pelvic Health Institute of Illinois can verify applicable benefits and provide a written estimate when appropriate. Ask about your expected out-of-pocket responsibility before beginning the treatment course.
Is PTNS treatment covered by insurance?
Coverage varies by insurance plan and individual circumstances, so it should be confirmed before treatment. The practice team can review your benefits and explain what information is available, but your insurer makes the final coverage determination. Bring your insurance details to the consultation so the question can be addressed directly.
Can I get PTNS treatment at home?
PTNS is an office-based treatment that uses a thin needle electrode near the ankle and is typically delivered during a series of clinician-supervised visits. Other forms of tibial nerve stimulation may be marketed for home use, but they are not automatically the same treatment. Do not substitute a home device without discussing it with a qualified clinician.
What side effects can PTNS cause?
Some patients notice mild, temporary discomfort or tingling during treatment. Reported minor effects include irritation, redness, or slight bleeding where the needle was inserted, as well as temporary aching around the ankle. Tell your clinician about symptoms that concern you or do not settle after the visit. Review common reported effects.
Ready to discuss your bladder symptoms?
If urgency, frequency, nighttime urination, or urge leakage is affecting your daily life, an individualized evaluation can help clarify whether PTNS belongs in your treatment plan. Request a consultation or schedule with Dr. Johnson to discuss your symptoms and possible next steps.